Incyte (INCY) Operating Expenses (2010 - 2026)

Incyte's Operating Expenses history runs 17 years deep, the most recent figure standing at $971.6 million for Q1 2026.

• Quarterly Operating Expenses rose 14.61% year-over-year to $971.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (down 11.52% YoY) and the FY2025 annual result came in at $3.6 billion, down 13.24% from the prior year.
• Operating Expenses was $971.6 million for Q1 2026 at Incyte, down from $1.2 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $1.5 billion in Q2 2024 and bottomed at $616.7 million in Q1 2022.
• A 5-year average of $862.8 million and a median of $826.1 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses soared 100.03% — and 2025, when it plunged 54.98%.
• Incyte's Operating Expenses stood at $856.6 million in 2022, then fell by 3.56% to $826.1 million in 2023, then climbed by 6.19% to $877.2 million in 2024, then soared by 33.49% to $1.2 billion in 2025, then fell by 17.03% to $971.6 million in 2026.
• Business Quant data shows INCY's Operating Expenses at $971.6 million in Q1 2026, $1.2 billion in Q4 2025, and $922.5 million in Q3 2025.